Takeda Pharmaceutical : Partial Correction to the Notice of Convocation of 147th Ordinary General Meeting of Shareholders

June 23, 2023

Dear Shareholders

Christophe Weber

President and Representative Director

Takeda Pharmaceutical Company Limited

1-1, Doshomachi 4-chome

Chuo-ku, Osaka

Partial Correction to the Notice of Convocation of the 147th Ordinary General Meeting

of Shareholders

Takeda Pharmaceutical Company Limited (the "Company") hereby reports that there is a part to be corrected in the Notice of Convocation of the 147th Ordinary General Meeting of Shareholders (the "Notice") and that the Company therefore decided to make a correction to the said part as described herein below.

1. Correction part:

The number of Company Shares owned by Mr. Christophe Weber, which is described in the Second Proposal (page 8) in the "Reference Document for the General Meeting of Shareholders" of the Notice

2. Contents of the correction:

	(Underlined sections indicate changes)
Before correction
Number of Company Shares Owned	378,100 shares
	↓
After correction
Number of Company Shares Owned	628,100 shares

[End of document]